Xinyao Feng

TRAIL-modified, doxorubicin-embedded periodic mesoporous organosilica nanoparticles for targeted drug delivery and efficient antitumor immunotherapy.

Xianghui Yu, Wenmo Liu, Bin Yu, 2022, Acta biomaterialia.

Oncolytic adenovirus-mediated intratumoral expression of TRAIL and CD40L enhances immunotherapy by modulating the tumor microenvironment in immunocompetent mouse models.

Xianghui Yu, Wenmo Liu, Jiaxin Wu, 2022, Cancer letters.

A tropism-transformed Oncolytic Adenovirus with Dual Capsid Modifications for enhanced Glioblastoma Therapy

Xianghui Yu, Wenmo Liu, Lizheng Wang, 2020, Journal of Cancer.

Recombinant AAV8-mediated intrastriatal gene delivery of CDNF protects rats against methamphetamine neurotoxicity

Xianghui Yu, Wenmo Liu, Lizheng Wang, 2017, International journal of medical sciences.

Measurement report: Spatiotemporal and policy-related variations of PM2.5 composition and sources during 2015–2019 at multiple sites in a Chinese megacity

Yinchang Feng, Yingze Tian, Feng-xia Huang, 2021, Atmospheric Chemistry and Physics.

20(s)-ginsenoside Rh2 promotes TRAIL-induced apoptosis by upregulating DR5 in human hepatocellular carcinoma cells

Xianghui Yu, Wenmo Liu, Bin Yu, 2021, Medical Oncology.

Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression

Xianghui Yu, Wenmo Liu, Lizheng Wang, 2017, PloS one.

Periodic Mesoporous Organosilica as a Nanoadjuvant for Subunit Vaccines Elicits Potent Antigen-Specific Germinal Center Responses by Activating Naive B Cells.

Wei Li, Xianghui Yu, Wenmo Liu, 2023, ACS nano.

Dose-related immunomodulatory effects of recombinant TRAIL in the tumor immune microenvironment

Xianghui Yu, Wenmo Liu, Lizheng Wang, 2023, Journal of Experimental & Clinical Cancer Research.